Is Sarda Proteins Ltd debt-free?

Yes, Sarda Proteins Ltd is debt-free with a debt-to-equity ratio of 0.00.

Home

Sarda Proteins Ltd

Sarda Proteins Ltd Financials

Sarda Proteins Ltd Financial Statement

Sarda Proteins Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	10.96	TBA	24.05
Operating Expense	11.45	0.10	23.95
Net Profit	-0.49	-0.11	0.10
Net Profit Margin	-4.47	TBA	0.42
Earning Per Share	-2.86	-0.65	0.56
EBIDTA	-0.49	-0.11	0.10
Effective Tax Rate	TBA	TBA	TBA

Particulars	Jun 2025
Revenue	10.96
Operating Expense	11.45
Net Profit	-0.49
Net Profit Margin	-4.47
Earning Per Share	-2.86
EBIDTA	-0.49
Effective Tax Rate	TBA

Sarda Proteins Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	24.19	1.30	5.80
Operating Expenses Annual	24.17	1.44	5.94
Operating Profit Annual	0.02	0.02	0.01
Interest Annual	TBA	0.00	TBA
Depreciation	TBA	TBA	TBA
Net Profit Annual	0.01	0.02	-0.03
Tax Annual	0.02	-0.00	0.05

Particulars	Mar 2025
Total Revenue Annual	24.19
Operating Expenses Annual	24.17
Operating Profit Annual	0.02
Interest Annual	TBA
Depreciation	TBA
Net Profit Annual	0.01
Tax Annual	0.02

Sarda Proteins Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.12	0.18	0.33
Cash Flow from Operations	-0.11	-0.23	-0.30
Cash Flow from Investing	TBA	0.17	0.16
Cash Flow from Financing	0.03	TBA	TBA
Cash Flow at the End	0.03	0.12	0.18

Particulars	Mar 2025
Cash Flow at the Beginning	0.12
Cash Flow from Operations	-0.11
Cash Flow from Investing	TBA
Cash Flow from Financing	0.03
Cash Flow at the End	0.03

Sarda Proteins Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	0.08	1.54	0.17
PBIT Margin (%)	0.08	1.54	0.17
PBT Margin (%)	0.08	1.54	0.17
Net PROFIT Margin (%)	0.04	1.54	-0.52
Return On Networth / Equity (%)	0.40	0.82	TBA
Return On Networth /Employed (%)	1.18	0.81	TBA
Return On Assets (%)	0.41	0.83	-1.25
Total Debt / Equity (X)	TBA	TBA	TBA
Asset Turnover Ratio (%)	10.02	0.54	2.42

Particulars	Mar 2025
PBDIT Margin (%)	0.08
PBIT Margin (%)	0.08
PBT Margin (%)	0.08
Net PROFIT Margin (%)	0.04
Return On Networth / Equity (%)	0.40
Return On Networth /Employed (%)	1.18
Return On Assets (%)	0.41
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	10.02

Sarda Proteins Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	TBA	0.00	0.00
Total Current Assets Annual	2.53	2.30	2.27
Non Current Assets Annual	0.12	0.14	0.14
Total Shareholders Funds Annual	2.38	2.37	2.35
Total Assets Annual	2.65	2.43	2.40

Particulars	Mar 2025
Fixed Assets Annual	TBA
Total Current Assets Annual	2.53
Non Current Assets Annual	0.12
Total Shareholders Funds Annual	2.38
Total Assets Annual	2.65

Sarda Proteins Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Sarda Proteins Ltd Financials

As of Oct 26, 2025, Sarda Proteins Ltd has a market capitalization of 21.53 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sarda Proteins Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Sarda Proteins Ltd recorded a total revenue of approximately 24.19 Cr marking a significant milestone in the company's financial performance.

Sarda Proteins Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.7% annually, respectively..

Sarda Proteins Ltd's current PE ratio is 2153.00.

Sarda Proteins Ltd's ROCE averaged 0.7% from the FY ending March 2023 to 2025, with a median of 0.8%. It peaked at 0.8% in March 2025, reflecting strong capital efficiency over the period..

Sarda Proteins Ltd's latest EBIT is Rs. 0.02 Cr, surpassing the average EBIT of Rs. 0.02 Cr over the 5 years..